Highlights Bio Vitos Pharma AB

Equities

BIOVIT

SE0009320278

Market Closed - Nasdaq Stockholm Other stock markets 08:50:40 31/05/2024 pm IST			5-day change	1st Jan Change
0.133 ^SEK	-4.32%		-13.64%	-44.12%

14/02	Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI
14/02	Bio Vitos Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	14/02	CI
Bio Vitos Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	14/02	CI
Bio Vitos Pharma Teams Up with KFUM Kalmar to Explore Benefits of Iron Succinate for Female Athletes	12/02	MT
KFUM Kalmar and Bio Vitos Pharma Sign Collaboration Agreement to Conduct Research Study on Succifer	12/02	CI
The European Patent Office EPO Grants Patent to Bio Vitos Pharma AB	20/12	CI
Hemcheck Sweden AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	16/11	CI
Hemcheck Sweden AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	30/23/30	CI
Hemcheck Sweden AB Receives A First Order from Its Distributor Astemed	15/23/15	CI
Hemcheck Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2023	09/23/09	CI
Hemcheck Sweden Receives New Follow Up Order from the Foundation for Innovative New Diagnostics	26/23/26	CI
Hemcheck Sweden AB Receives First Order from the University Hospital Charité in Berlin	06/23/06	CI
Hemcheck Sweden AB Receives First Follow Up Order from Its Finnish Distributor	13/23/13	CI
Hemcheck Sweden AB Receives an Additional Follow-Up Order from Its Uk Distributor	02/23/02	CI
Hemcheck Receives Follow Up Order from Research Program in the United States	01/23/01	CI
Hemcheck Sweden AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	14/23/14	CI
Hemcheck Sweden AB Reports Earnings Results for the Full Year Ended December 31, 2022	14/23/14	CI
YRRO Ltd agreed to acquire Hemcheck Sweden AB (OM:HEMC) in a reverse merger transaction for SEK 85.7 million.	08/23/08	CI
Hemcheck Sweden AB Receives Follow-Up Order from Eurobio Scientific	03/23/03	CI
Hemcheck Sweden AB Receives Follow-Up Order from CLS	01/23/01	CI
Hemcheck Receives First Order from Landspitali	24/23/24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Bio Vitos Pharma AB

Equities

BIOVIT

SE0009320278

Highlights

Filters